These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol. Woodman RJ; Playford DA; Watts GF Diabetes Res Clin Pract; 2006 Jan; 71(1):59-67. PubMed ID: 16029909 [TBL] [Abstract][Full Text] [Related]
9. The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients. Westhoff TH; Schmidt S; Glander P; Liefeld L; Martini S; Offermann G; Neumayer HH; Zidek W; van der Giet M; Budde K Nephrol Dial Transplant; 2007 Aug; 22(8):2354-8. PubMed ID: 17526535 [TBL] [Abstract][Full Text] [Related]
10. Selective impairment of endothelium-mediated vasodilation in liver transplant recipients with cyclosporin A-induced hypertension. Albillos A; Cacho G; Barrios C; Alvarez-Mon M; Rossi I; Gómez-Arnau J; Pérez-Páramo M; Calleja JL; Muñoz J; Torres MT; Daza R; Cuervas-Mons V; Escartín P Hepatology; 1998 Feb; 27(2):332-8. PubMed ID: 9462627 [TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levels. Mercanoglu F; Turkmen A; Kocaman O; Pinarbasi B; Dursun M; Selcukbiricik F; Sever MS Transplant Proc; 2004 Jun; 36(5):1357-60. PubMed ID: 15251332 [TBL] [Abstract][Full Text] [Related]
13. Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. White M; Ross H; Haddad H; LeBlanc MH; Racine N; Pflugfelder P; Giannetti N; Davies R; Azevedo E; Isaac D; Burton J; Ferguson R; Genest J Transplantation; 2006 Sep; 82(6):763-70. PubMed ID: 17006323 [TBL] [Abstract][Full Text] [Related]
14. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation. Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903 [TBL] [Abstract][Full Text] [Related]
15. The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients. Strózecki P; Adamowicz A; Włodarczyk Z; Manitius J Ren Fail; 2007; 29(6):679-84. PubMed ID: 17763162 [TBL] [Abstract][Full Text] [Related]
17. Renal and metabolic effects of L-arginine infusion in kidney transplant recipients. Zhang XZ; Ghio L; Ardissino G; Tirelli AS; Daccò V; Testa S; Claris-Appiani A Clin Nephrol; 1999 Jul; 52(1):37-43. PubMed ID: 10442494 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients. Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599 [TBL] [Abstract][Full Text] [Related]
19. Studies on effects of calcineurin inhibitor withdrawal on arterial distensibility and endothelial function in renal transplant recipients. Kosch M; Hausberg M; Suwelack B Transplantation; 2003 Nov; 76(10):1516-9. PubMed ID: 14657697 [TBL] [Abstract][Full Text] [Related]
20. Role of heart failure etiology on arterial wave reflection in heart transplant recipients: relation with C-reactive protein. Pierce GL; Schofield RS; Nichols WW; Hill JA; Braith RW J Hypertens; 2007 Nov; 25(11):2273-9. PubMed ID: 17921822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]